Overview
Christoph Ehlken practices in Kiel, Germany. Mr. Ehlken is rated as an Experienced expert by MediFind in the treatment of Mesenteric Venous Thrombosis. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Vein Occlusion, Vitrectomy, and Trabeculectomy.
His clinical research consists of co-authoring 27 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Mesenteric Venous Thrombosis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Age-Related Macular Degeneration (ARMD)
- Late-Onset Retinal DegenerationMr. Ehlken isAdvanced. Learn about Late-Onset Retinal Degeneration.
- Retinal Vein OcclusionMr. Ehlken isAdvanced. Learn about Retinal Vein Occlusion.
- Experienced
- Central Serous ChorioretinopathyMr. Ehlken isExperienced. Learn about Central Serous Chorioretinopathy.
- Diabetic Macular Edema (DME)Mr. Ehlken isExperienced. Learn about Diabetic Macular Edema (DME).
- Diabetic RetinopathyMr. Ehlken isExperienced. Learn about Diabetic Retinopathy.
- Mesenteric Venous ThrombosisMr. Ehlken isExperienced. Learn about Mesenteric Venous Thrombosis.
- Retinal DetachmentMr. Ehlken isExperienced. Learn about Retinal Detachment.
- TrabeculectomyMr. Ehlken isExperienced. Learn about Trabeculectomy.